România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida aurobindo 25 mg
apl swift services (malta) ltd. - malta - lenalidomidum - caps. - 25mg - imunosupresoare alte imunosupresoare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida aurobindo 5 mg
apl swift services (malta) ltd. - malta - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida teva 5 mg
teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
Uniunea Europeană -
română -
EMA (European Medicines Agency)
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agenți antineoplazici - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 2,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 2,5mg - imunosupresoare alte imunosupresoare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 20 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 7,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
Uniunea Europeană -
română -
EMA (European Medicines Agency)
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - mielom multiplu - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
thiotepa fresenius kabi 100 mg
fresenius kabi deutschland gmbh - germania - thiotepum - pulb. pt. conc. pt. sol. perf. - 100mg - agenti alchilanti agenti alchilanti
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
thiotepa fresenius kabi 15 mg
fresenius kabi deutschland gmbh - germania - thiotepum - pulb. pt. conc. pt. sol. perf. - 15mg - agenti alchilanti agenti alchilanti